Biobanking Market Report on Untapped Growth
Pune, April 11, 2022 (GLOBE NEWSWIRE) — The world biobank market is driven by a high incidence of chronic diseases such as cardiovascular disease, Alzheimer’s disease, arthritis and diabetes. Additionally, factors such as an increase in R&D funding, technological advances in regenerative medicine, developments in drug discovery, and increased awareness of stem cell therapies. The increasing number of research activities used to predict drug reactions is expected to support the growth of this market.
The global biobank market is estimated to reach over USD 82.17 billion by 2030, it is expected to grow at a CAGR of over 7.8% during the forecast period from 2022 to 2030.
Biobanking Market by Region
The global biobank market can be segmented into North America, Europe, Asia-Pacific, and Rest of the World (ROW). Currently, North America dominates the biobanking market due to factors such as increasing research activities, large investments in the field of genomics, and growing interest in biomarker discovery. Additionally, the Asia-Pacific region is expected to propel the biobanking market over the forecast period, with a significant CAGR. The presence of a large population base in this region, especially in countries like India and China, will drive the market. Also, increase in infrastructure facilities in life sciences, along with increase in funds from government organizations in this field, is expected to boost the market in this region.
Get a sample copy of the report https://www.marketdatacentre.com/sample/70
- COMPANY PROFILES (Business Overview, Products and Services Offered, Financial Performance, R&D Intensity, Marketing and Sales Intensity, Recent Developments, Analysts’ Corner)*
- Thermo Fisher Scientific Inc.
- PHC Holding Company
- QIAGEN AG
- Becton, Dickinson and company
- Merck KGaA
- Hamilton Company
- Avantor, Inc.
- Tecan Group Ltd.
- Promega Corporation
- Market definition
- Market ecosystem
- Market classification
- Geographic scope
- Years considered for the study: historical years – 2017 and 2020; Reference year – 2021; Planned years – 2022 to 2030
- Currency used
- RESEARCH METHODOLOGY
- Research framework
- Data collection technique
- Information source
- Secondary sources
- Primary sources
- Market estimation methodology
- Bottom-up approach
- Top-down approach
- Data validation and triangulation
- Market Forecast Model
- Study limitations/assumptions
- STUDY SUMMARY
- ASSESSMENT OF MARKET DYNAMICS
- UNIQUE SELLING PROPOSALS (USP)
- Technological advances
- Research Landscape Assessment
- GLOBAL BIOBANKS MARKET – ANALYSIS AND FORECASTS, BY PRODUCTS AND SERVICES
- Sample analysis equipment
- Sample processing equipment
- Sample transport equipment
- Storage equipment
- Analysis Consumables
- Processing Consumables
- Gathering Consumables
- Storage Consumables
- Provisioning Services
- Transportation services
- Processing services
- Storage services
Vendor assessment includes an in-depth analysis of how vendors meet the demand in the biobank market. The MDC Competetive Scape model was used to assess the qualitative and quantitative information for this assessment. MDC’s Competitive Scape is a structured method to identify key players and describe their strengths, relevant characteristics and outreach strategy. MDC’s Competitive Scape enables organizations to analyze the environmental factors that influence their business, set goals and identify new marketing strategies. MDC Research analysts conduct in-depth investigation into solutions, services, programs, marketing, organization size, geographic focus, organization type, and vendor strategies.
Technology has a huge impact on business productivity, growth and efficiency. Technologies can help companies develop competitive advantages, but choosing them can be one of the most demanding decisions for companies. Technology assessment helps organizations understand their current technology situation and offers them a roadmap towards which they might want to evolve and grow their business. A well-defined process for evaluating and selecting technology solutions can help organizations reduce risk, achieve their goals, identify the problem, and fix it the right way. Technology assessment can help companies identify which technologies to invest in, meet industry standards, and compete with competitors.
Download sample PDF https://www.marketdatacentre.com/samplepdf/70
Business ecosystem analysis
Advances in technology and digitalization have changed the way companies do business; the business ecosystem concept helps companies understand how to thrive in this changing environment. Business ecosystems offer organizations the opportunity to integrate technology into their day-to-day business operations and improve their research and business skills. The business ecosystem comprises a network of interconnected businesses that compete and cooperate to increase sales, improve profitability, and succeed in their markets. An ecosystem analysis is a business network analysis that includes the relationships between suppliers, distributors, and end users in the delivery of a product or service.
Regions and countries covered
North America (US, Canada), Europe (Germany, UK, France, Spain, Italy and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, Rest of Asia- Pacific) and Rest of the World (Row)
Biobanks Market Dynamics, Impact of Covid-19 on the Biobanks Market, Vendor Profiles, Vendor Assessment, Strategies, Technology Assessment, Product Mapping, Industry Outlook, Economic Analysis, Segmental Analysis, Market Sizing biobanks market, analysis charts
Buy the report now https://www.marketdatacentre.com/checkout/70
Supplier Profiles Covered
All major Tier 1, 2 and 3 companies are covered in this Biobanking Market report (25 Vendor Profiles)
Answers to key questions in this report:
- What is the market potential for biobanks?
- What is the impact of COVID-19 on the global biobank market?
- What are the key strategies adopted by companies in the Biobanking market?
- What are the challenges faced by SMEs and major vendors in the biobanking market?
- Which region has the highest investments in the Biobanking market?
- What is the latest research and activity for the Biobank market?
- Who are the key players in the Biobanking market?
- What is the market potential for biobanks?
Additional vendor profiles can be added based on customer business needs
At MDC Research, we offer research solutions to help companies break through the barriers of doubt or uncertainty when considering expanding their growth. Our researchers compile data and insights that help CEOs decide which growth opportunities in a market to pursue.
MDC Research is known for producing well-researched reports, and the expertise of our researchers contributes to the exceptional quality of our reports. MDC Research enables companies to make impactful decisions by combining innovation and analytical thinking. Our unique blend of these two skills ensures you have access to the most comprehensive and up-to-date information about your industry.
MDC Research has extensive experience in using the latest methodologies to develop reports for a wide range of clients in various markets. Our commitment to providing high-quality research and creating innovative reports is one of the reasons why MDC Research is such a trusted name in the business world today.
Read the report preview https://www.marketdatacentre.com/biobanking-market-70
Market Data Center (subsidiary of Yellow Bricks Global Services Private Limited)
Market Data Center offers comprehensive solutions for market research reports in various businesses.These decision-making processes depend on extremely important and systematic information created through in-depth study along with latest trends going on in the market. industry. The company is also trying to offer much better friendly services and proper business information to make our customers’ ideas come true.